Answers are grounded in this paper and cite their sources.
Background To make informed decisions about cancer screening, people need access to understandable, evidence-based, and transparent information. While prior studies show quality gaps in online information, it remains unclear whether official European cancer screening information materials meet these standards. Objective This study evaluated the quality of official online information materials for organized breast, cervical, and colorectal cancer screening programs across Europe as part of the European Joint Action on Cancer Screening project. Methods We conducted a descriptive cross-sectional study. Between October 2024 and April 2025, we collected 182 official online materials on breast, cervical, and colorectal cancer screening from 26 European countries and translated them into English. We evaluated their quality using the validated Mapping the Quality of Health Information checklist for assessing the extent (0%-100%) to which the materials support informed decision-making across 4 domains: definition, transparency, content, and presentation. Results The mean score was 25.7% (SD 15.0%), ranging from 6.8% to 78.3%, with no differences by cancer type. Sixteen of the 182 materials achieved a score of 50% or higher, and 3 exceeded 75%. The definition domain achieved the highest mean score (60.3%, SD 21.9%). The transparency domain obtained the lowest score (8.8%, SD 9.4%), with none of the materials reporting conflicts of interest or systematic search strategies. Most materials avoided persuasive language (n=143, 78.6%) and narrative elements (n=159, 87.4%). Mean scores for adequate presentation were 15.4% (SD 36.1%) for benefits, 13.2% (SD 33.8%) for harms, and 14.8% (SD 35.5%) for test accuracy. Information on cancer prevalence or incidence was mentioned in 20.9% (n=38) of the materials. Conclusions Most analyzed information materials showed limited adherence to criteria considered important for informed decision-making. There are major shortcomings in transparency and in the communication of benefits and harms.
No takes yet. Share an insight, caveat, or question.
Kerschner et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: